Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02093520 · ClinicalTrials.gov registry record · NA
The MiDAS ENCORE Study
A NA study, sponsored by Vertos Medical.
- Completed
- Registry status
- NA
- Development phase
- 302
- Enrollment target
NCT02093520 is a NA study that has completed, run by Vertos Medical. The registered enrollment target is 302 participants.
The verdict
NCT02093520, a NA study, has completed, sponsored by Vertos Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 302 participants
- Enrollment target
Study Summary
Study Objective: To compare patient outcomes following treatment with either the MILD procedure or epidural steroid injections (ESIs) in patients with painful lumbar spinal stenosis exhibiting neurogenic claudication and having verified ligamentum flavum hypertrophy as a contributing factor.
Interventions
- PROCEDURE MILD Procedure
- DRUG Epidural Steroid Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2014-05 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02093520
The ClinicalTrials.gov registry entry for NCT02093520 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 302 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vertos Medical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MILD Procedure is the first listed.
NCT02093520 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02093520 about?
NCT02093520 is a clinical study titled "The MiDAS ENCORE Study". Study Objective: To compare patient outcomes following treatment with either the MILD procedure or epidural steroid injections (ESIs) in patients with painful lumbar spinal stenosis exhibiting neurogenic claudication and having verified ligamentum flavum hypertrophy as a contributing factor.
What is the current status of trial NCT02093520?
This trial is currently completed. It is a NA study. The enrollment target is 302 participants. The study started on 2014-05. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02093520?
The interventions under investigation include: MILD Procedure (PROCEDURE), Epidural Steroid Injection (DRUG).
Who is sponsoring clinical trial NCT02093520?
This trial is sponsored by Vertos Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.